Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Management of Bleeding During Abortion Procedures with Tranexamic Acid

Dosing and Administration

  • Tranexamic acid (TXA) should be administered early (within 3 hours) at a dose of 1g IV over 10 minutes as part of standard care for significant bleeding during abortion procedures, with a second 1g dose if bleeding continues after 30 minutes or restarts within 24 hours 1, 2, 3
  • A second dose of 1g IV should be administered if bleeding continues after 30 minutes or if bleeding restarts within 24 hours of the first dose 3, 4
  • TXA must be administered within 3 hours of the onset of bleeding for maximum benefit 5, 6
  • Early administration is crucial as benefit decreases by 10% for every 15-minute delay 6, 4

Clinical Indications During Abortion Procedures

  • TXA is indicated for clinically significant bleeding during abortion procedures, defined as blood loss sufficient to compromise hemodynamic stability 1, 3
  • TXA should be given regardless of whether bleeding is due to genital tract trauma or other causes 2, 6
  • TXA should be considered part of the standard treatment package for significant bleeding, not just as a rescue therapy when other treatments fail 3, 4

Mechanism of Action

  • TXA is a synthetic lysine analogue that acts as a competitive inhibitor of plasminogen, reducing fibrinolysis 7

Efficacy and Benefits

  • Early TXA administration (within 1 hour) significantly reduces mortality due to bleeding 5, 7

Integration with Other Treatments

  • TXA should be used as part of a comprehensive treatment approach that includes fluid replacement, uterotonics, monitoring of vital signs, non-surgical interventions, and surgical interventions when necessary 1, 4, 8

Important Cautions and Contraindications

  • TXA should NOT be given more than 3 hours after the onset of bleeding as it may increase the risk of harm 5, 6
  • TXA is contraindicated in women with known thromboembolic events during pregnancy 6, 4
  • Healthcare facilities providing abortion care should ensure availability of TXA and proper training for staff to administer it safely 6, 8

Practical Implementation

  • Consider protocols that enable early TXA administration, similar to trauma care protocols 5, 9
  • Ensure IV access is established early in cases with potential for significant bleeding 10, 7
  • Facilities should have TXA readily available wherever abortion procedures are performed 6, 8